Do mothers pass anti-interferon antibodies to their babies?
Part of Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at whether mothers pass certain immune system proteins (called anti-interferon alpha autoantibodies) to their baby during pregnancy. It is for pregnant women who have conditions like lupus or type 1 diabetes, or who already know they have these antibodies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pregnant woman age 18 or older
- Your pregnancy is less than 30 weeks along
- You have a condition often linked to anti-interferon alpha antibodies (like lupus, severe COVID-19, type 1 diabetes, or certain autoimmune diseases) or you already know you have those antibodies
- You are willing to get a blood test for these antibodies before 30 weeks of pregnancy
- You plan to give birth at the study center
- You are covered by French Social Security
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers in the mother's blood that might predict how exposure to inflammation during pregnancy could change a baby's brain development. The goal is to understand these effects in healthy pregnancies and those with certain inflammatory conditions.
This study looks at a protein called interferon in the blood of people with cancer who are starting immunotherapy, and people with certain autoimmune diseases (such as lupus, Sjögren's syndrome, scleroderma, or inflammatory myopathy). The goal is to compare interferon patterns and better understand immune responses.
This study tests an experimental drug (IMSB301) for people with rare genetic conditions that cause too much type 1 interferon activity (a part of the immune system). The goal is to see if the drug is safe and can help reduce symptoms.
This study is a pregnancy and health registry for women with autoimmune (immune system) conditions who are trying to become pregnant or are already pregnant. It helps researchers better understand pregnancy outcomes and health needs in autoimmune disease.
This study is for adults whose immune system has trouble fighting viruses due to specific antibodies or a genetic condition. Researchers want to follow these people over time to better understand the condition and improve care.
This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.
Hear when a new Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.